pamrevlumab
mAbexperimental
Pamrevlumab is a humanized monoclonal antibody designed for the treatment of idiopathic pulmonary fibrosis and pancreatic cancer. It binds to the connective tissue growth factor (CTGF) protein. — Wikipedia
Clinical trial activity
19 trials · 46 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
12
Phase 3
6
Phase 4
0
Earliest trial started Dec 18, 2003 (NCT00074698)
Timeline
Indications
Studied for
Mechanism of action
- Connective tissue growth factorINHIBITOR
CCN2 inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaPamrevlumab ↗
- ChEMBLCHEMBL2109377 ↗
Also known as
- fg3019
- fg 3019
- fg-3019
- fg-3019
- fg-3019
- fg-3019
- pamrevlumab
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04632940 | Phase 3 | Dec 31, 2020 | FibroGen |
| NCT04419558 | Phase 3 | Aug 31, 2020 | FibroGen |
| NCT04432298 | Phase 2 | Jun 30, 2020 | FibroGen |
| NCT04371666 | Phase 3 | May 30, 2020 | FibroGen |
| NCT05262309 | Phase 2/Phase 3 (Phase 3) | May 12, 2020 | Universita' Cattolica del Sacro Cuore |
| NCT03955146 | Phase 3 | Jun 30, 2019 | FibroGen |
| NCT03941093 | Phase 3 | May 10, 2019 | FibroGen |
| NCT02851381 | N/A | Aug 1, 2016 | University of California, Los Angeles |
| NCT02606136 | Phase 2 | Nov 1, 2015 | FibroGen |
| NCT02210559 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2014 | FibroGen, Virginia Mason Medical Center |
| NCT01890265 | Phase 2 | Jun 1, 2013 | Avanza Research, Bharti Hospital, Columbia University, Dartmouth University, Daw Park Repatriation, Australia, Dunedin Public Hospital, New Zealand, Emory University, FibroGen, Fortis Hospitals, India, Henry Ford Health System, Into Research, South Africa, Legacy Health System, Life Mount Edgecombe Hospital, South Africa, Midland Healthcare & Research Center, India, Northwestern University, Pulmonix LLC, USA, Rajiv Gandhi University of Health Sciences, Sri Bala Medical Centre and Hospital, India, Stellenbosch University, Tauranga Hospital, New Zealand, The University of Texas, Dallas, Tokuda Hospital, Tufts University, University of Alabama, Birmingham, University of California, Davis, University of California, Los Angeles, University of Cincinnati, University of Colorado, Denver, University of Kansas, University of Louisville, University of Maryland, University of Otago, University of Pittsburgh, University of Sydney, University of Utah, Vanderbilt University, Vermont Lung Center, Via Christi Regional Medical Center, Waikato Hospital, Yale University |
| NCT01262001 | Phase 2 | Mar 1, 2011 | FibroGen |
| NCT01217632 | Phase 2 | Aug 1, 2010 | FibroGen |
| NCT00913393 | Phase 2 | Feb 1, 2009 | FibroGen |
| NCT01181245 | Phase 1 | Dec 1, 2008 | Case Western Reserve University, Dartmouth University, FibroGen, Oregon Health and Science University, Stanford University, University of Pennsylvania, University of Pittsburgh, Virginia Mason Medical Center |
| NCT00782561 | Phase 1 | Apr 1, 2008 | FibroGen |
| NCT00754143 | Phase 1 | Mar 1, 2008 | FibroGen |
| NCT00102297 | Phase 1 | Jan 1, 2005 | FibroGen |
| NCT00074698 | Phase 1 | Dec 18, 2003 | FibroGen |
Showing 19 of 19 trials
Page 1 / 1
Organizations
Research & Development (46)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| FibroGen | For profit | 17 | 17 | 3 | 2003 |
| Dartmouth University | Academic/Hospital | 2 | 0 | 2 | 2008 |
| University of California, Los Angeles | Academic/Hospital | 2 | 1 | 2 | 2013 |
| University of Pittsburgh | Academic/Hospital | 2 | 0 | 2 | 2008 |
| Virginia Mason Medical Center | Academic/Hospital | 2 | 0 | 2 | 2008 |
| Avanza Research | For profit | 1 | 0 | 1 | 2013 |
| Bharti Hospital | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Case Western Reserve University | Academic/Hospital | 1 | 0 | 1 | 2008 |
| Columbia University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Daw Park Repatriation, Australia | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Dunedin Public Hospital, New Zealand | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Emory University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Fortis Hospitals, India | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Henry Ford Health System | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Into Research, South Africa | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Legacy Health System | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Life Mount Edgecombe Hospital, South Africa | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Midland Healthcare & Research Center, India | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Northwestern University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Oregon Health and Science University | Academic/Hospital | 1 | 0 | 1 | 2008 |
46 organizations
Page 1 / 3